The Role of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors in the Treatment of Heart Failure in Patients with Type 2 Diabetes Mellitus. APMPLMI [Internet]. 2022 May 13 [cited 2025 Oct. 30];3(1):1-10. Available from: https://apmplmi.com/index.php/apmp/article/view/42